You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Beta cell

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 1 Diabetes Trial in Seattle (Verapamil)

Completed
  • Type 1 Diabetes
  • Seattle, Washington
    Benaroya Research Institute
Apr 27, 2023

Diabetes, Type 1 Trial (Ketogenic diet, food delivery and education, Standard diet, food delivery and education)

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • Ketogenic diet, food delivery and education
  • Standard diet, food delivery and education
  • (no location specified)
Jun 1, 2023

Type 1 Diabetes Trial in Nijmegen (68Ga-NODAGA-Exendin-4)

Recruiting
  • Type 1 Diabetes
  • Nijmegen, Gelderland, Netherlands
    Radboud University Medical Center
Nov 17, 2022

type1diabetes, Type2diabetes, Pre Diabetes Trial in Parma (68Ga-exendin-4, mixed meal test)

Recruiting
  • type1diabetes
  • +3 more
  • Parma, Pr, Italy
    Azienda Ospedaliero Universitaria di Parma
Dec 20, 2022

Glucose Intolerance Trial (Dorzagliatin, Placebo)

Not yet recruiting
  • Glucose Intolerance
  • (no location specified)
Jul 21, 2022

PreDiabetes Trial (Beef, Poultry)

Not yet recruiting
  • PreDiabetes
  • Beef
  • Poultry
  • (no location specified)
Jul 12, 2022

Type 1 Diabetes Trial in Indianapolis (Acetylated and Butyrylated High Amylose Maize Starch)

Recruiting
  • Type 1 Diabetes
  • Acetylated and Butyrylated High Amylose Maize Starch
  • Indianapolis, Indiana
    Indiana University School of Medicine
Aug 19, 2022

Diabetes, Type 2 Trial in San Antonio (Dapagliflozin, Exenatide, Placebo)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • San Antonio, Texas
    University of Texas Health Science Center
Sep 12, 2022

Diabetes, Type 2 Trial in Hong Kong (Dorzagliatin, )

Completed
  • Diabetes Mellitus, Type 2
  • Hong Kong, Hong Kong
    The Chinese University of Hong Kong
Jul 19, 2022

Type 1 Diabetes Trial in Amsterdam (encapsulated autologous fecal microbiota transplantation)

Recruiting
  • Type 1 Diabetes
  • encapsulated autologous fecal microbiota transplantation
  • Amsterdam, Please Select, Netherlands
    Academisch Medisch Centrum
Apr 5, 2022

Diabetes Trial in Vienna, Paris (68Ga-NODAGA-exendin-4 PET/CT)

Recruiting
  • Diabetes Mellitus
  • 68Ga-NODAGA-exendin-4 PET/CT
  • Vienna, Austria
  • +1 more
Jun 16, 2022

Beta Cell Imaging in T1D a Different Glycemic Control

Terminated
  • Type 1 Diabetes Mellitus
  • gallium-68-exendin PET/CT
  • Nijmegen, Gelderland, Netherlands
    Radboudumc
Jan 29, 2022

Anhydroglucitol in Children With Type 1 Diabetes

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • Measurement of blood levels of 1,5-anhydroglucitol
  • (no location specified)
Oct 25, 2022

Type1 Diabetes Trial in United States (HCL, verapamil 120mg tablet, non-HCL)

Completed
  • Type1 Diabetes
  • HCL
  • +3 more
  • Palo Alto, California
  • +5 more
Oct 31, 2022

Type 2 Diabetes Trial (aerobic exercise, high-intensity interval exercise training, resistance exercise training)

Not yet recruiting
  • Type 2 Diabetes
  • aerobic exercise
  • +2 more
  • (no location specified)
Apr 18, 2022

Sickle Cell Anemia, Beta Thalassemia Trial run by the NHLBI (radiation, drug, biological)

Recruiting
  • Sickle Cell Anemia
  • Beta Thalassemia
  • TBI
  • +6 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

Type 1 Diabetes Trial in Idaho Falls, Seattle (Liraglutide, Golimumab)

Completed
  • Type 1 Diabetes Mellitus
  • Idaho Falls, Idaho
  • +1 more
Jan 21, 2022

Type2 Diabetes, Obesity, Morbid Trial in Hvidovre (Oral Glucose Tolerance Test, Hyperglycemic clamp with infusion of saline,

Completed
  • Type2 Diabetes
  • Obesity, Morbid
  • Oral Glucose Tolerance Test
  • Hyperglycemic clamp with infusion of saline, GLP-1 or GIP
  • Hvidovre, Denmark
    Hvidovre University Hospital
Mar 14, 2022

Beta Cell Dysfunction Trial in Shanghai (overexpression STRA6/miRNA3)

Completed
  • Beta Cell Dysfunction
  • overexpression STRA6/miRNA3
  • Shanghai, Shanghai, China
    Xiaoyun Cheng
Oct 8, 2022

COVID19, BETA-CELL FUNCTION Trial in Milan (Stimulation test with arginine infusion in order to verify the possible existence of

Recruiting
  • COVID19
  • BETA-CELL FUNCTION
  • Stimulation test with arginine infusion in order to verify the possible existence of damage to the beta cell function induced by COVID-19 infection
  • Milan, MI, Italy
    Sacco University Hospital
Sep 27, 2021

Type 1 Diabetes Trial in Worcester (Ergocalciferol, Placebo)

Completed
  • Type 1 Diabetes
  • Worcester, Massachusetts
    University of Massachusetts Medical School
Jan 9, 2022

Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Non-Hodgkin Lymphoma, Refractory B Acute Lymphoblastic Leukemia Trial

Not yet recruiting
  • Recurrent B Acute Lymphoblastic Leukemia
  • +5 more
  • Interferon Beta-1A
  • +10 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 6, 2023

Sickle Cell Disease, Thalassemia, Stem Cell Transplantation Trial run by the National Heart, Lung, and Blood Institute (NHLBI)

Recruiting
  • Sickle Cell Disease
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +6 more
  • Miltenyi CliniMACS Prodigy ® system
  • (no location specified)
Mar 23, 2023

Mitapivat in Subjects With Sickle Cell Disease

Enrolling by invitation
  • Sickle Cell Anemia
  • +7 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023